Korean Circulation Journal

The Korean Society of Cardiology (대한심장학회)
권호 표지
DOI QR코드

DOI QR Code

Successful Percutaneous Coronary Intervention for Acute Coronary Syndrome in a Patient With Severe Hemophilia A

  • Kim, Dong-Kie (Division of Cardiology, Department of Internal Medicine, Inje University College of Medicine, Busan Paik Hospital) ;
  • Kim, Doo-Il (Division of Cardiology, Department of Internal Medicine, Inje University College of Medicine, Busan Paik Hospital) ;
  • Kim, Mo-Se (Division of Cardiology, Department of Internal Medicine, Inje University College of Medicine, Busan Paik Hospital) ;
  • Lee, Eun-Ji (Division of Cardiology, Department of Internal Medicine, Inje University College of Medicine, Busan Paik Hospital) ;
  • Kim, Young-Bok (Division of Cardiology, Department of Internal Medicine, Inje University College of Medicine, Busan Paik Hospital) ;
  • Cho, Hwan-Jin (Division of Cardiology, Department of Internal Medicine, Ulsan Hospital) ;
  • Han, Yang-Chun (Division of Cardiology, Department of Internal Medicine, Changwon Fatima Hospital) ;
  • Kim, Ung (Division of Cardiology, Department of Internal Medicine, Inje University College of Medicine, Busan Paik Hospital) ;
  • Seol, Sang-Hoon (Division of Cardiology, Department of Internal Medicine, Inje University College of Medicine, Busan Paik Hospital) ;
  • Yang, Tae-Hyun (Division of Cardiology, Department of Internal Medicine, Inje University College of Medicine, Busan Paik Hospital) ;
  • Kim, Dae-Kyung (Division of Cardiology, Department of Internal Medicine, Inje University College of Medicine, Busan Paik Hospital) ;
  • Kim, Dong-Soo (Division of Cardiology, Department of Internal Medicine, Inje University College of Medicine, Busan Paik Hospital)
  • Received : 2009.12.03
  • Accepted : 2010.02.20
  • Published : 2010.10.30
⟨ Previous Next ⟩

Abstract

Patients with hemophilia generally have a reduced frequency of coronary artery disease compared to the general population. As advances in the management of hemophilia have increased their life expectancy, the prevalence of coronary artery disease also has increased. However, there are no standard treatment guidelines for coronary artery disease in patients with hemophilia, especially in the field of coronary intervention. We report the case of a patient with severe hemophilia A who presented with acute coronary syndrome and was successfully treated with percutaneous coronary intervention.

Keywords

References

  1. Plug I, van der Born JG, Peters M, et al. Mortality and causes of death in patients with hemophilia, 1992-2001: a prospective cohort study. J Thromb Haemost 2006;4:510-6. https://doi.org/10.1111/j.1538-7836.2006.01808.x
  2. Rosendaal FR, Briet E, Stibbe J, et al. Haemophilia protects against ischaemic heart disease: a study of risk factors. Br J Haematol 1990;75:525-30. https://doi.org/10.1111/j.1365-2141.1990.tb07793.x
  3. Srmek A, Kriek M, Rosendaal FR. Decreased mortality of ischaemic heart disease among carriers of haemophilia. Lancet 2003;362:351-4. https://doi.org/10.1016/S0140-6736(03)14021-4
  4. Srmek A, Reiber JH, Gerrits WB, Rosendaal FR. Decreased coagulability has no clinically relevant effect on atherogenesis: observations in individuals with a hereditary bleeding tendency. Circulation 2001;104:762-7. https://doi.org/10.1161/hc3501.094232
  5. Girolami A, Ruzzon E, Fabris F, Varvarikis C, Sartori R, Girolami B. Myocardial infarction and other arterial occlusions in hemophilia a patients. a cardiological evaluation of all 42 cases reported in the literature. Acta Haematol 2006;116:120-5. https://doi.org/10.1159/000093642
  6. Bond L, Bevan D. Myocardial infarction in a patient with hemophilia treated with DDAVP. N Engl J Med 1988;318:121.
  7. Arora U, Dhir M, Cintron G, Strom JA. Successful multi-vessel percutaneous coronary intervention with bivalirudin in a patient with severe hemophilia A: a case report and review of literature. J Invasive Cardiol 2004;16:330-2.
  8. Krolick MA. Successful percutaneous coronary intervention in a patient with severe haemophilia A using bivalirudin as the sole procedural anticoagulant. Haemophilia 2005;11:415-7. https://doi.org/10.1111/j.1365-2516.2005.01103.x
  9. Park DW, Park SW. Stent thrombosis in the era of the drug-eluting stent. Korean Circ J 2005;35:791-4.
  10. Brener SJ, Steinhubl SR, Berger PB, Brennan DM, Topol EJ. Prolonged dual antiplatelet therapy after percutaneous coronary intervention reduces ischemic events without affecting the need for repeat revascularization: insights from the CREDO trial. J Invasive Cardiol 2007;19:287-90.
  11. Bovenzi F, De Luca L, Signore N, Fusco F, de Luca I. Abciximab for the treatment of an acute thrombotic coronary occlusion during stent implantation in a patient with severe hemophilia B. Ital Heart J 2003;4:728-30.
  12. MacKinlay N, Taper J, Renisson F, Rickard K. Cardiac surgery and catheterization in patients with haemophilia. Haemophilia 2000;6:84-8.
  13. Ferrario C, Renders F, Cairoli A, Vuffray A, Spertini O, Angelillo-Scherrer A. Management of an acute coronary syndrome in a patient tvv with severe haemophilia A. Haemophilia 2007;13:763-5. https://doi.org/10.1111/j.1365-2516.2007.01530.x

Cited by

  1. Percutaneous coronary intervention in patients with haemophilia presenting with acute coronary syndrome: an interventional dilemma: case series, review of the literature, and tips for management vol.35, pp.2, 2013, https://doi.org/10.1007/s11239-012-0802-y
  2. Discrepant ratios of arterial versus venous thrombosis in hemophilia A as compared with hemophilia B vol.37, pp.3, 2010, https://doi.org/10.1007/s11239-013-0943-7
  3. Current Therapeutic Approach to Acute Myocardial Infarction in Patients with Congenital Hemophilia vol.11, pp.10, 2010, https://doi.org/10.3390/life11101072